Works matching IS 09509232 AND DT 2010 AND VI 29 AND IP 47

Results: 10

Mast cells have a protumorigenic role in human thyroid cancer.

Published in:

Oncogene, 2010, v. 29, n. 47, p. 6203, doi. 10.1038/onc.2010.348

By:

Melillo, R M;
Guarino, V;
Avilla, E;
Galdiero, M R;
Liotti, F;
Prevete, N;
Rossi, F W;
Basolo, F;
Ugolini, C;
de Paulis, A;
Santoro, M;
Marone, G

Publication type:

Article

Suppression of cell-cycle progression by Jun dimerization protein-2 (JDP2) involves downregulation of cyclin-A2.

Published in:

Oncogene, 2010, v. 29, n. 47, p. 6245, doi. 10.1038/onc.2010.355

By:

Pan, J;
Nakade, K;
Huang, Y-C;
Zhu, Z-W;
Masuzaki, S;
Hasegawa, H;
Murata, T;
Yoshiki, A;
Yamaguchi, N;
Lee, C-H;
Yang, W-C;
Tsai, E-M;
Obata, Y;
Yokoyama, K K

Publication type:

Article

DNA damage stress response in germ cells: role of c-Abl and clinical implications.

Published in:

Oncogene, 2010, v. 29, n. 47, p. 6193, doi. 10.1038/onc.2010.410

By:

Gonfloni, S

Publication type:

Article

CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells.

Published in:

Oncogene, 2010, v. 29, n. 47, p. 6257, doi. 10.1038/onc.2010.357

By:

Chen, K-F;
Liu, C-Y;
Lin, Y-C;
Yu, H-C;
Liu, T-H;
Hou, D-R;
Chen, P-J;
Cheng, A-L

Publication type:

Article

Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis.

Published in:

Oncogene, 2010, v. 29, n. 47, p. 6222, doi. 10.1038/onc.2010.349

By:

Nogueira, C;
Kim, K-H;
Sung, H;
Paraiso, K H T;
Dannenberg, J-H;
Bosenberg, M;
Chin, L;
Kim, M

Publication type:

Article

ERK and JNK activation is essential for oncogenic transformation by v-Rel.

Published in:

Oncogene, 2010, v. 29, n. 47, p. 6267, doi. 10.1038/onc.2010.359

By:

Kralova, J;
Sheely, J I;
Liss, A S;
Bose, H R

Publication type:

Article

ALDH1L1 inhibits cell motility via dephosphorylation of cofilin by PP1 and PP2A.

Published in:

Oncogene, 2010, v. 29, n. 47, p. 6233, doi. 10.1038/onc.2010.356

By:

Oleinik, N V;
Krupenko, N I;
Krupenko, S A

Publication type:

Article

PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy.

Published in:

Oncogene, 2010, v. 29, n. 47, p. 6280, doi. 10.1038/onc.2010.344

By:

Salvati, E;
Scarsella, M;
Porru, M;
Rizzo, A;
Iachettini, S;
Tentori, L;
Graziani, G;
D'Incalci, M;
Stevens, M F G;
Orlandi, A;
Passeri, D;
Gilson, E;
Zupi, G;
Leonetti, C;
Biroccio, A

Publication type:

Article

The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44<sup>+</sup> cells.

Published in:

Oncogene, 2010, v. 29, n. 47, p. 6294, doi. 10.1038/onc.2010.365

By:

Dhillon, J;
Astanehe, A;
Lee, C;
Fotovati, A;
Hu, K;
Dunn, S E

Publication type:

Article

Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.

Published in:

Oncogene, 2010, v. 29, n. 47, p. 6216, doi. 10.1038/onc.2010.363

By:

Hadfield, K D;
Smith, M J;
Urquhart, J E;
Wallace, A J;
Bowers, N L;
King, A T;
Rutherford, S A;
Trump, D;
Newman, W G;
Evans, D G

Publication type:

Article